Summary
Hyungseok S is an Assistant Professor and cancer immunologist with 11 years of experience bridging academic and industry research in Seoul and abroad. He holds a Ph.D. in Immunology from Seoul National University and brings hands-on expertise in CAR-T cell therapy, cancer vaccines, CRISPR, next-generation sequencing, and in vivo tumor models. Previously a Principal Scientist at Novartis NIBR and a postdoc at La Jolla Institute, his work has focused on epigenetic reprogramming and the molecular drivers of NK and T cell dysfunction in tumors, including NFAT, Nr4a, Tox, and TET enzyme pathways. He led translational efforts such as a Phase I clinical trial for a B cell–based cancer vaccine and now directs the Seo Lab for Cell & Gene Therapy, applying mechanistic insights to therapeutic development. Colleagues describe him as methodical and relentless—aptly reflected by his GitHub motto, "Do or Do not. There is No Trying..."
10 years of coding experience
2 years of employment as a software developer
Doctor of Philosophy - PhD, Immunology, Doctor of Philosophy - PhD, Immunology at Seoul National University